Kailera Therapeutics Names Scott M. Akamine As Chief Legal Officer

Nov 12, 2024•about 1 year ago

Position

Chief Legal Officer

Company

Kailera Therapeutics

Scott M. Akamine

WalthamresearchBiotechnologyHealth Care

Description

Kailera Therapeutics, Inc. announces the appointment of Scott M. Akamine as Chief Legal Officer

Company Information

Company

Kailera Therapeutics

Location

890 Winter Street

Waltham, Massachusetts, United States

About

Kailera Therapeutics (Kailera) is developing a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Kailera’s most advanced program, KAI-9531 (being developed in China as HRS9531), is an injectable GLP-1/GIP receptor dual agonist that demonstrated positive clinical trial results in obesity in China. The Company is also advancing a diversified pipeline leveraging several mechanisms and routes of delivery. Kailera’s mission is to develop next-generation weight management therapies that give people the power to transform their lives and elevate their overall health.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Kailera Therapeutics Names Scott M. Akamine As Chief Legal Officer

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Executive Insights

Company Information